These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3181446)

  • 1. The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
    Williams MR; Turkes A; Pearson D; Twining P; Griffiths K; Blamey RW
    Eur J Surg Oncol; 1988 Oct; 14(5):417-22. PubMed ID: 3181446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
    Williams MR; Turkes A; Pearson D; Griffiths K; Blamey RW
    Eur J Surg Oncol; 1990 Feb; 16(1):22-7. PubMed ID: 2137790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R; Schröder G; Garbrecht M; Frahm H
    Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
    Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
    Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
    Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
    Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
    Buzdar AU; Jones SE; Vogel CL; Wolter J; Plourde P; Webster A
    Cancer; 1997 Feb; 79(4):730-9. PubMed ID: 9024711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
    Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
    Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythmic fluctuations of CEA serum levels in breast cancer patients.
    Jäger W; Diedrich M; Sauerbrei W; Wildt L
    Anticancer Res; 1987; 7(4B):711-5. PubMed ID: 3674759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
    Williams MR; Turkes A; Pearson D; Griffiths K; Blamey RW
    Br J Cancer; 1990 Jan; 61(1):126-32. PubMed ID: 2137007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
    Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.